Previous Article |
Table of Contents
| Next Article 
BIOCHEMISTRY
Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli
¶
Departments of *Chemical Engineering,
Chemistry, and
Biochemistry, Stanford University, Stanford, CA
94305; and Department of Biological Chemistry
and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115
Edited by Chi-Huey Wong, The Scripps Research Institute, La Jolla, CA, and approved June 19, 2003 (received for review April 14, 2003)
Ansamycins such as rifamycin, ansamitocin, and geldanamycin are an important class of polyketide natural products. Their biosynthetic pathways are especially complex because they involve the formation of 3-amino-5-hydroxybenzoic acid (AHBA) followed by backbone assembly by a hybrid nonribosomal peptide synthetase/polyketide synthase. We have reconstituted the ability to synthesize 2,6-dimethyl-3,5,7-trihydroxy-7-(3'-amino-5'-hydroxyphenyl)-2,4-heptadienoic acid (P8/1-OG), an intermediate in rifamycin biosynthesis, in an extensively manipulated strain of Escherichia coli. The parent strain, BAP1, contains the sfp phosphopantetheinyl transferase gene from Bacillus subtilis, which posttranslationally modifies polyketide synthase and nonribosomal peptide synthetase modules. AHBA biosynthesis in this host required introduction of seven genes from Amycolatopsis mediterranei, which produces rifamycin, and Actinosynnema pretiosum, which produces ansamitocin. Because the four-module RifA protein (530 kDa) from the rifamycin synthetase could not be efficiently produced in an intact form in E. coli, it was genetically split into two bimodular proteins separated by matched linker pairs to facilitate efficient inter-polypeptide transfer of a biosynthetic intermediate. A derivative of BAP1 was engineered that harbors the AHBA biosynthetic operon, the bicistronic RifA construct and the pccB and accA1 genes from Streptomyces coelicolor, which enable methylmalonyl-CoA biosynthesis. Fermentation of this strain of E. coli yielded P8/1-OG, an N-acetyl P8/1-OG analog, and AHBA. In addition to providing a fundamentally new route to shikimate and ansamycin-type compounds, this result enables further genetic manipulation of AHBA-derived polyketide natural products with unprecedented power.
Abbreviations: AHBA, 3-amino-5-hydroxybenzoic acid; P8/1-OG, 2,6-dimethyl-3,5,7-trihydroxy-7-(3'-amino-5'-hydroxyphenyl)-2,4-heptadienoic acid; LM, nonribosomal peptide synthetase-like loading module; amu, atomic mass units; M3N, 6-deoxyerythronolide B synthase N-terminal linker region of eryM3; M2C, 6-deoxyerythronolide B synthase C-terminal linker region of eryM2.
¶ To whom correspondence should be addressed. E-mail: ck{at}chemeng.stanford.edu.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
|
|
 |
|
  K. S. Ryan, C. J. Balibar, K. E. Turo, C. T. Walsh, and C. L. Drennan The Violacein Biosynthetic Enzyme VioE Shares a Fold with Lipoprotein Transporter Proteins J. Biol. Chem., March 7, 2008; 283(10): 6467 - 6475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Chung, H. K. Lim, J.-C. Kim, G. J. Choi, E. J. Park, M. H. Lee, Y. R. Chung, and S.-W. Lee Forest Soil Metagenome Gene Cluster Involved in Antifungal Activity Expression in Escherichia coli Appl. Envir. Microbiol., February 1, 2008; 74(3): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Peiru, H. G. Menzella, E. Rodriguez, J. Carney, and H. Gramajo Production of the Potent Antibacterial Polyketide Erythromycin C in Escherichia coli Appl. Envir. Microbiol., May 1, 2005; 71(5): 2539 - 2547. [Abstract] [Full Text] [PDF]
|
|
